BioSpace News Archive

Mr. Lucier’s commitment to disruptive technology and global scale accelerated Company growth to more than $1 billion in net sales

Record quarterly results highlighted by revenue of $27.1 million and pre-tax income of $15.8 million

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs ™ ), today announced that management will be participating in the following virtual investor conferences: Guggenheim Healthcare Talks—Genomic Medicines

MAIA Biotechnology, Inc. , a biotechnology company focused on the development of targeted, first-in-class oncology drugs, today announced that company management is presenting at the following virtual investor conferences:

Athersys, Inc. (NASDAQ: ATHX) announced today its fourth quarter 2020 and annual 2020 financial results and recent highlights.

EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical-stage company developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system, today announced financial results for the year ended December 31, 2020 and provided an update on recent corporate and operational activities.

Triple-S Management Corporation (NYSE: GTS), a leading health services company in Puerto Rico, today announced that it has appointed Victor J. Haddock-Morales as Executive Vice President and Chief Financial Officer, effective May 10, 2021

Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today provides a business update and reports financial results for the quarter and full year ended December 31, 2020. Management is hosting an earnings call today at 4:30 p.m. ET.

Varian (NYSE: VAR) today announced a new investment in Bend It Technologies Ltd., a medical device company based in Petach Tikva, Israel, that is developing the Bendit® steerable microcatheters for use by interventionalists performing minimally-invasive peripheral vascular procedures.

Avenova ® unit sales set record for second consecutive quarter Net product revenue increased 51% for 2020 Exited 2020 with $12.0 million in cash and equivalents Avenova access expanded to CVS stores and CVS online